Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 30 of 100

WHO Measles Free Countries

Countries Are Losing ‘Measles Free’ Designation and the U.S. Could Be Next: Brainstorm Health

By Sy Mukherjee

FDA Cancer Drug Trials Placebo

FDA: Some Cancer Patients Shouldn’t Be Forced to Take Placebos in Drug Trials: Brainstorm Health

By Sy Mukherjee

The Diseases That Are Increasingly Killing Americans: Brainstorm Health

By Sy Mukherjee

Marijuana Research DEA

The DEA Will Finally Help Expand Marijuana Research: Brainstorm Health

By Sy Mukherjee

The U.S. May Have Had Its First Vaping-Related Death: Brainstorm Health

By Sy Mukherjee

Obamacare Profits

Obamacare Plans Are Turning a Profit: Brainstorm Health

By Sy Mukherjee

Genetic Counseling for a Million Person Study: Brainstorm Health

By Sy Mukherjee

NIH All of Us Color Genomics

This Company Will Provide Genetic Counseling for a Million Person NIH Study

By Sy Mukherjee

BRCA Gene Breast Cancer Testing USPSTF

U.S. Panel Says More Women Should Get BRCA Gene Testing for Breast Cancer: Brainstorm Health

By Sy Mukherjee

Healthcare Change the World 2019

The Surprising Health Care Companies Changing the World: Brainstorm Health

By Sy Mukherjee

FDA drug approvals Roche Celgene AbbVie

The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health

By Sy Mukherjee

FDA graphic cigarette warnings

Can Disturbing Graphics Scare People Off of Cigarettes?—Brainstorm Health

By Sy Mukherjee

Novartis Zolgensma brother scientists

The Fallout from Novartis’ Alleged Data Manipulation: Brainstorm Health

By Sy Mukherjee

USPSTF drug use testing

A Federal Panel Says All Adults Should Be Screened for Drug Addiction: Brainstorm Health

By Sy Mukherjee

Ebola drugs cure Congo

A Promising Pair of Ebola Drugs Raises Hopes in Africa: Brainstorm Health

By Sy Mukherjee